USPTO trademark

SERVING OVERLOOKED PATIENTS

RegisteredUSPTOWord markClass 5

"SERVING OVERLOOKED PATIENTS" is a word mark owned by Azurity Pharmaceuticals, Inc., filed at the USPTO on April 29, 2022. It is registered and covers class 5 (Pharmaceuticals).

View Azurity Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
SERVING OVERLOOKED PATIENTS trademark as filed
As filed with the USPTO
Status
Registered
Since March 24, 2026
Filed
April 29, 2022
Registered
March 24, 2026
Expires
Not recorded
Application no.
97388326
Registration no.
8187953
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns SERVING OVERLOOKED PATIENTS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Azurity Pharmaceuticals, Inc.

Woburn, United States

125 trademarks in the portfolioView company

Representative

Douglas R. Wolf

Wolf, Greenfield & Sacks, P.C.

Goods and services

What the mark covers

The products and services SERVING OVERLOOKED PATIENTS is filed for, grouped by Nice class.

  • Pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, and anti-inflammatory, antimicrobial, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle spasm, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; antibiotics; pharmaceutical products for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders having vancomycin, enalapril, lisinopril, and methotrexate as the active pharmaceutical ingredient; antacids; muscle relaxants; hormone replacement medicines; topical anti-inflammatory and ultrasound gels; pharmaceutical preparation for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders, and for the treatment and prevention of renal, oncological, inflammatory, gastrointestinal, gastroesophageal, and cardio-vascular diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Notice of acceptance of statement of use e-mailed
  4. Allowed principal register - sou accepted
  5. Statement of use processing complete
  6. Notice of approval of extension request e-mailed
  7. Sou extension 4 granted
  8. Case assigned to intent to use paralegal
  9. Use amendment filed
  10. Sou teas extension received

10 earlier steps on the official record.

FAQ

About SERVING OVERLOOKED PATIENTS

Who owns the trademark "SERVING OVERLOOKED PATIENTS"?

The USPTO trademark "SERVING OVERLOOKED PATIENTS" (application 97388326) is owned by Azurity Pharmaceuticals, Inc.

What is the status of "SERVING OVERLOOKED PATIENTS"?

Its status at the USPTO is: registered.

When was "SERVING OVERLOOKED PATIENTS" registered?

It was registered on March 24, 2026.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SERVING OVERLOOKED PATIENTS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a7e-3747-7168-bdb7-efff0b910b30
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a7e-3747-7168-bdb7-efff0b910b30",
  "object": "trademark",
  "mark_text": "SERVING OVERLOOKED PATIENTS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97388326",
  "filing_date": "2022-04-29",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Azurity Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb725-e6a7-73db-81c8-7bbc8473b1bf"
    }
  ]
}